PureTech Health — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Seaport Therapeuticsseaporttx.com in 𝕏NASDAQ: SPTXOct 2024 · $225M

Seaport Therapeutics develops therapeutics and medicines.

BiotechMental HealthBoston, US

Daphne Zohar(Founder, CEO & Board Member)inSteven Paul, M.D.(Founder, Board Chair)inMichael Chen, Ph.D.(Co-Founder, Chief Scientific Officer)Michael Chen(Executive Officer)inLana Gladstein(Executive Officer)inAntony Loebel(Executive Officer)in

Co-investorsARCH Venture Partners Foresite Capital General Atlantic HAWKTAIL Sofinnova Ventures CPP Investments +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.